Proposed Federal Law Would Mandate Annual HIPAA Audits, $1.3B in Hospital Funding
The Health Infrastructure Security and Accountability Act reintroduced September 17 requires independent audits, CEO attestations, and biennial security standards. HHS would audit 20 entities annually.
Federal mandate would replace risk-based HIPAA with auditable controls
Democratic senators reintroduced the Health Infrastructure Security and Accountability Act on September 17, requiring HHS to establish minimum cybersecurity standards for all HIPAA-covered entities and business associates, updated at least every two years. The bill moves healthcare security from the current risk-based governance model to federally defined, independently auditable controls.
The proposal includes $1.3 billion in federal funding: $800 million for rural and underserved urban hospitals and $500 million in incentives for all hospitals meeting enhanced cybersecurity goals. HHS would conduct annual audits of at least 20 HIPAA-regulated entities, prioritizing organizations considered systemically important.
Concrete requirements include annual security risk analyses evaluating risks from business associates, independent compliance audits against HHS cybersecurity practices, and annual CEO and CISO attestations certifying compliance with applicable security standards. Organizations must maintain continuity and recovery plans, including stress tests for cyberattacks, technical failures, and natural disasters.
Proposed civil penalties range from $500 for violations committed without knowledge to $250,000 for uncorrected willful neglect. The bill does not mandate specific vendors or technologies, shifting competitive advantage toward platforms that produce audit-ready evidence, third-party risk management, recovery testing, and executive attestation workflows.
Procurement priorities shift to evidence collection and control validation
Healthcare CIOs should treat the proposal as a budget signal rather than an immediately enforceable requirement. The bill would require quantifiable spending for annual risk assessments, independent audits, business-associate monitoring, immutable backup and recovery testing, endpoint and identity controls, and executive-level compliance reporting.
Organizations purchasing platforms now should favor products that map controls to HIPAA, NIST, and HHS cybersecurity goals and retain evidence suitable for independent audits. The proposed funding could offset implementation costs for eligible hospitals, but the legislation does not change current HIPAA obligations while it remains pending.
GRC platforms including Diligent, Archer, ServiceNow, OneTrust, and LogicGate benefit from the emphasis on control effectiveness, audit readiness, and third-party risk management. Healthcare-specific compliance platforms such as Medcurity and security vendors including Microsoft, Palo Alto Networks, CrowdStrike, and Cisco compete on the underlying controls the bill would measure.
Ambry Genetics settlement establishes $700,000 phishing benchmark
HHS's Office for Civil Rights announced a $700,000 settlement with Ambry Genetics following a phishing attack affecting approximately 225,000 individuals. The enforcement action links a large breach to deficiencies addressable through concrete controls: phishing-resistant authentication, email security, security-risk analysis, workforce training, detection, and incident response.
The settlement gives healthcare executives a concrete loss scenario for investment cases. Buyers should ask whether vendors can document phishing-resistant MFA coverage, privileged-account protection, email telemetry, training completion, risk-analysis findings, remediation tickets, and incident-response evidence.
Phishing-resistant identity products from Microsoft, Okta, Cisco Duo, and Yubico, email-security platforms from Proofpoint and Microsoft, and compliance platforms such as Medcurity, ServiceNow, and Archer benefit. The competitive distinction shifts from basic awareness training toward demonstrable prevention and evidence that the organization assessed and mitigated phishing risk.
HIPAA Security Rule overhaul remains unresolved through 2027
Federal officials were still assessing the proposed overhaul of the HIPAA Security Rule as of September 21. Industry reporting indicated that implementation of any final rule could be delayed until at least early 2028, extending planning uncertainty for healthcare organizations.
The uncertainty favors vendors offering flexible compliance mappings rather than products hard-coded to one future rule. Buyers face a timing decision: defer major purchases until the rule is finalized or invest in controls that satisfy both current HIPAA obligations and likely future requirements.
The safer procurement approach prioritizes capabilities with value under existing rules—asset inventories, system-activity logging, remote-access controls, vulnerability management, incident response, recovery testing, and business-associate oversight—while requiring vendors to commit to rapid regulatory updates.
What to watch
HHS released version 3.7 of the ONC/OCR Security Risk Assessment Tool, addressing assessment scope, remote access and telework, asset inventories, system-activity logging, and triggers for reassessment. The free tool establishes a baseline workflow that smaller providers can adopt without purchasing a platform, forcing commercial vendors to differentiate through automation, continuous monitoring, integrations, evidence retention, third-party risk management, and executive reporting.
The near-term requirement remains HIPAA's existing risk-based Security Rule, but three signals indicate spending priorities: the proposed legislation's emphasis on audit readiness and business-associate risk, OCR's $700,000 phishing settlement, and the updated assessment tool's focus on remote access, logging, and asset inventory. Buyers should favor platforms that retain evidence, map controls to multiple frameworks, and automate reassessment triggers over products requiring manual documentation.
Technology decisions, clearly explained.
Weekly analysis of the tools, platforms, and strategies that matter to B2B technology buyers. No fluff, no vendor spin.
